Several brokerages have updated their recommendations and price targets on shares of CareDx (NASDAQ: CDNA) in the last few weeks: 5/31/2024 – CareDx had its “neutral” rating reaffirmed by analysts at HC Wainwright. 5/29/2024 – CareDx was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating. 5/21/2024 – CareDx was upgraded […]

Related Keywords

United States , Craig Hallum , Raymond James , Investment Management , Caredx Inc , Bellevue Group , Vanguard Group Inc , News Ratings For Caredx Inc Daily , Goldman Sachs Group Inc , Gagnon Securities , Kent Lake Capital , Goldman Sachs Group , Get Free Report , Allosure Kidney , Allomap Heart , Allosure Heart , Allosure Lung , Caredx Inc Daily ,